Overview

Chemotherapy for Patients With Osteosarcoma

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of your participation in this study is to help answer the following research questions, and not to provide you treatment for your condition. - To assess how well treatment with pemetrexed works for patients with your type of cancer - To assess for any side effects that might be associated with pemetrexed. - To look at the characteristics and levels of certain of your genes and proteins to learn more about osteosarcoma and how pemetrexed works in your body.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Pemetrexed